Third Rock Ventures News
Most Popular Third Rock Ventures Story
VC launches $378M fund
Boston-based Third Rock Ventures has launched a fund with $378 million of committed capital that will be used to invest in life sciences companies at the early stages of formation. Third Rock said... Read more...
Latest Headlines
- September 14, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
